IP Library › Granted Patent US 12,551,652
Granted Patent B2
US 12,551,652 · App. 18/636,960 · Granted Feb 17, 2026

System and method for non-invasive ventilation

Inventors: Sascha Kristopher Zoellner (Auckland, NZ); Bhavna Prentice (Auckland, NZ); Joseph Jules Nihotte (Auckland, NZ); Grant Leigh Nelson (Auckland, NZ); James Alexander Gordon (Auckland, NZ); Brendan O'Neill (Auckland, NZ)
Assignee: Fisher & Paykel Healthcare Limited
A61M16/206A61M16/0875A61M16/0883A61M16/1015A61M16/161A61M16/208A61M2205/3334A61M2205/3368
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,551,652
App. No.
18/636,960
Granted
Feb 17, 2026
Kind
B2
Abstract

Systems and methods for non-invasive ventilation are provided. The systems may include a gas source that provides breathing gases to a patient through one or more of a primary flow path (PFP) and a flushing flow path (FFP). The system may include a control assembly configured to open and restrict gas flow through the PFP. When the PFP is open, a significant portion of the gas flows through the PFP while the remaining gas flows through the FFP. When the PFP is restricted, a significant portion of the gas flows through the FFP. Increased flow through the FFP may have a high velocity (especially relative to the flow through the PFP). Gas delivered through the FFP may be used to flush dead space. One or both flow paths may contribute to inspiratory positive airway pressure (IPAP), expiratory positive airway pressure (EPAP), and/or positive end expiratory pressure (PEEP).

Claims (15)

1 . A method for providing non-invasive ventilation to a patient, the method comprising:

providing positive pressure breathing gases to a patient through a patient interface apparatus comprising a sealing mask forming a seal with a mouth and a nose of the patient, an inlet that receives the positive pressure breathing gases from a pressurized gas flow source, and a gas outlet;

wherein:

during patient inhalation, the flow of gas is provided to the patient through one or more of the mouth and the nose of the patient; and

during patient exhalation, a flow restrictor of the patient interface apparatus is configured to increase a portion of the positive pressure breathing gases along a flow path that provides anatomical dead space flushing through a nasal cavity of the patient and out through the gas outlet.

2 . The method of claim 1 , wherein the flow restrictor causes the increase in the portion of the positive pressure breathing gases along the flow path that provides anatomical dead space flushing based at least in part on an increase of pressure within the patient interface apparatus.

3 . The method of claim 2 , wherein the increase in pressure within the patient interface apparatus is further caused by exhalation of the patient.

4 . The method of claim 2 , wherein the flow path that provides anatomical dead space flushing comprises flow through a non-sealing cannula comprising two prongs positioned within a chamber that seals about the mouth and nose of the patient.

5 . The method of claim 1 , wherein the flow restrictor is configured to cause the increase in the portion of the positive pressure breathing gases along the flow path that provides anatomical dead space flushing during patient exhalation and to a start of patient inhalation.

6 . The method of claim 1 , wherein the flow path that provides anatomical dead space flushing comprises flow in through the nose of the patient, out through the mouth of the patient or out through the nose of the patient, and out through the gas outlet.

7 . The method of claim 1 , wherein the sealing mask comprises a non-sealing cannula comprising two prongs positioned within a chamber that seals about the mouth and nose of the patient.

8 . The method of claim 7 , wherein each of the two prongs is configured in size and shape to direct and/or accelerate at least a portion of the positive pressure breathing gases into nares of the patient.

9 . The method of claim 1 , wherein the gas outlet comprises a bias vent.

10 . The method of claim 1 , wherein the gas outlet is configured to connect to an expiratory limb.

11 . The method of claim 1 , wherein the positive pressure breathing gases are provided continuously.

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE THE SECOND INVENTOR'S NAME FROM O'NEILL, BREDEN TO O'NEILL BRENDAN PREVIOUSLY RECORDED AT REEL: 67137 FRAME: 333. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Oct 16, 2024
From: ZOELLNER, SASCHA KRISTOPHER; O'NEILL, BRENDAN; PRENTICE, BHAVNA; NIHOTTE, JOSEPH JULES; NIHOTTE, JOSEPH JULES; NELSON, GRANT LEIGH; GORDON, JAMES ALEXANDER
To: FISHER & PAYKEL HEALTHCARE LIMITED
Reel/Frame 069176/0390 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2024
From: ZOELLNER, SASCHA KRISTOPHER; O'NEILL, BRENDEN; PRENTICE, BHAVNA; NIHOTTE, JOSEPH JULES; NELSON, GRANT LEIGH; GORDON, JAMES ALEXANDER
To: FISHER & PAYKEL HEALTHCARE LIMITED
Reel/Frame 067137/0333 →
Continuity (3)
Continuation 17040007
Provisional Application 62646745 · Mar 22, 2018
Related Publication 20240307650A1 · Sep 19, 2024
References Cited (32)
US 1362766A · Martin · 1920 [cited by applicant]
US 5005571A · Dietz · 1991 [cited by examiner]
US 5460174A · Chang · 1995 [cited by examiner]
US 6253767B1 · Mantz · 2001 [cited by applicant]
US 8136527B2 · Wondka · 2012 [cited by examiner]
US 8365731B2 · Ho · 2013 [cited by applicant]
US 8616209B2 · Amarasinghe · 2013 [cited by examiner]
US 10179218B2 · Ahmad · 2019 [cited by applicant]
US 10307562B2 · Cragg · 2019 [cited by applicant]
US 20020096178A1 · Ziaee · 2002 [cited by applicant]
US 20020170557A1 · Schmidt · 2002 [cited by examiner]
US 20040255948A1 · Smith · 2004 [cited by applicant]
US 20060112962A1 · Tebbutt · 2006 [cited by applicant]
US 20060201514A1 · Jones et al. · 2006 [cited by applicant]
US 20090032019A1 · Green · 2009 [cited by examiner]
US 20090159084A1 · Sher et al. · 2009 [cited by applicant]
US 20110315143A1 · Frater · 2011 [cited by examiner]
US 20150059759A1 · Frater · 2015 [cited by examiner]
US 20150128941A1 · Holley · 2015 [cited by applicant]
US 20160136371A1 · Rapoport · 2016 [cited by applicant]
US 20160220781A1 · Arrowsmith · 2016 [cited by applicant]
US 20210016050A1 · Zoellner et al. · 2021 [cited by applicant]
WO WO2009017952 · 2009 [cited by applicant]
WO 2013067592A1 · 2013 [cited by applicant]
WO WO2013171705 · 2013 [cited by applicant]
WO WO2015041545 · 2015 [cited by applicant]
WO WO2016157106 · 2016 [cited by applicant]
WO WO2017096428 · 2017 [cited by applicant]
WO 2018033863A1 · 2018 [cited by applicant]
WO 2019173869A1 · 2019 [cited by applicant]
PCT Search Report for International Search Report for PCT/IB2019/052329 dated Jul. 22, 2019. [cited by applicant]
Extended European Search Report for European Application No. 24164689.2 dated Aug. 20, 2024. [cited by applicant]